An intrauterine contraceptive device is a medical device, which is inserted in the uterus to prevent conception. A plastic string is attached to the end of the device to ensure correct placement and its removal. These devices are available in various forms, such as coil, loop, triangle, and T-shaped, and are made up of plastic or metal. An intrauterine contraceptive device may also be used as an emergency contraception method after unprotected sex. An intrauterine contraceptive device is inserted into the uterus with the help of health care professionals.
Increasing prevalence of unplanned pregnancies, less side-effects associated with intrauterine contraceptive devices, and implementation of affordable care are some of the key factors driving the growth of the global intrauterine contraceptive device market. In addition, increasing awareness about pregnancy is also driving the growth of the global intrauterine contraceptive device market.
Market Analysis and Insights: Global and China Intrauterine Contraceptive Market
This report focuses on global and China Intrauterine Contraceptive QYR Global and China market.
The global Intrauterine Contraceptive market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Intrauterine Contraceptive Scope and Market Size
Intrauterine Contraceptive market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Intrauterine Contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Intrauterine Contraceptive market is segmented into
Hormonal IUCD
Copper IUCD
Segment by Application, the Intrauterine Contraceptive market is segmented into
Hospitals
Gynecological Clinics
Other
Regional and Country-level Analysis
The Intrauterine Contraceptive market is analysed and market size information is provided by regions (countries).
The key regions covered in the Intrauterine Contraceptive market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Intrauterine Contraceptive market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Intrauterine Contraceptive business, the date to enter into the Intrauterine Contraceptive market, Intrauterine Contraceptive product introduction, recent developments, etc.
The major vendors covered:
Teva Pharmaceutical Industries
Medicines360
Trimedic Supply Network
Bayer Healthcare
Actavis
Medisafe Distribution
Pace Pharmaceuticals
...
Increasing prevalence of unplanned pregnancies, less side-effects associated with intrauterine contraceptive devices, and implementation of affordable care are some of the key factors driving the growth of the global intrauterine contraceptive device market. In addition, increasing awareness about pregnancy is also driving the growth of the global intrauterine contraceptive device market.
Market Analysis and Insights: Global and China Intrauterine Contraceptive Market
This report focuses on global and China Intrauterine Contraceptive QYR Global and China market.
The global Intrauterine Contraceptive market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Intrauterine Contraceptive Scope and Market Size
Intrauterine Contraceptive market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Intrauterine Contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Intrauterine Contraceptive market is segmented into
Hormonal IUCD
Copper IUCD
Segment by Application, the Intrauterine Contraceptive market is segmented into
Hospitals
Gynecological Clinics
Other
Regional and Country-level Analysis
The Intrauterine Contraceptive market is analysed and market size information is provided by regions (countries).
The key regions covered in the Intrauterine Contraceptive market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape
and Intrauterine Contraceptive Market Share AnalysisIntrauterine Contraceptive market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Intrauterine Contraceptive business, the date to enter into the Intrauterine Contraceptive market, Intrauterine Contraceptive product introduction, recent developments, etc.
The major vendors covered:
Teva Pharmaceutical Industries
Medicines360
Trimedic Supply Network
Bayer Healthcare
Actavis
Medisafe Distribution
Pace Pharmaceuticals
...
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.